Limited Evidence Suggests Metformin Might Be Beneficial to Reduce Head and Neck Cancer Risk and Increase Overall Survival, While Any Benefit With Antiinflammatory Drugs Is Inconsistent
- PMID: 31732106
- DOI: 10.1016/j.jebdp.2019.101340
Limited Evidence Suggests Metformin Might Be Beneficial to Reduce Head and Neck Cancer Risk and Increase Overall Survival, While Any Benefit With Antiinflammatory Drugs Is Inconsistent
Abstract
Article title and bibliographic information: Protective effects of metformin, statins, and antiinflammatory drugs on head and neck cancer: A systematic review. Saka Herrán C, Jané-Salas E, Devesa AE, López-López J. Oral Oncol 2018;85:68-81.
Source of funding: None.
Type of design: Systematic review with meta-analysis.
Keywords: Metformin; NSAIDs; Oral cancer; Oral cancer prevention; Oral cancer risk; Statins.
Copyright © 2019 Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
